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ABSTRACT
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Acquired Immunodeficiency Syndrome (AIDS) caused by Human Immunodeficiency Virus
(HIV) is a pernicious disease acknowledged as a world health problem. One of the major issues
in the study of AIDS is understanding the manifestation and the progression of the disease
following the transmission of HIV. Unfortunately, the present state of biological knowledge does
not yet give us a reliable means of evaluating these phenomena. A simulation approach is,
therefore, extremely useful in predicting the various phases of the deteriorating physiological
status of the patient. In the present study we have focused on the development of a mathematical
model of the immune response to HIV and subsequently the dynamics of AIDS progression. The
model is based on a set of ordinary differential equations solved using numerical analysis
techniques. The model predicts the response of the T4 helper cells, cytotoxic and natural killer
cells, macrophages and monocytes, and antibodies to the infection. Three cases are presented in
this thesis. Each case has a different initial concentration of the virus. The rate of depletion of the
immune cells is directly proportional to the increase in the initial concentration of the virus. These
model-based investigations show that the theoretical results generated by the model are in close
agreement with real life clinical observations of patients.
A hypothetical detoxification unit is proposed for the treatment of AIDS. It is believed that
this detox unit may not be able to cure the patient, but would at least increase the patient's life.
Simulation results of AIDS progression using this detox machine are plotted in this thesis. The
detox unit is in the experimental stage of blood separation. The experimental procedures and
results obtained from the detox machine up to this day are also presented in the following
chapters. Further research in this field is in progress.
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CHAPTER 1

INTRODUCTION
The immune system is a very complex network of white blood cells, proteins and
cofactors. It is mainly responsible for the protection of the body against foreign organisms.
Individual patients exhibit unique immune system profiles. Major parameters that affect the
individual's system response to the attacker include concentration levels of white blood cells
(WBC) and immunoglobulins (Ig), and the distribution of the WBC subpopulations and
immunoglobulins [1,2]. In characterizing the immune state it is also necessary to consider the
day-to-day and patient-to-patient variations in these physiological and biochemical functions.
Mathematical modeling capable of incorporating these parameters and therefore
accurately reflecting their influence on the system provides a powerful tool for predicting the
immune response.
In studies related to Acquired Immunodeficiency Syndrome (AIDS), such models for
simulating immune response are expected to provide information that may be critical in
understanding the etiology of the disease. The search for treatment, or at least longer survival for
an AIDS patient has gained increased momentum in recent years [3]. Current research has
focused on the design and testing of several anti-viral drugs for AIDS. With the growing need for
treatment of this fatal disease, simulation of the immune system can help us test and evaluate the
effect of different drugs (presently available as well as future possible solutions evolving from
research) on the patient.
In this thesis we have developed a mathematical model of the immune response to HIV in
order to understand the dynamics of AIDS progression. The model consists of a set of nonlinear,
first order differential equations. The model predicts the response of T4 helper cells, monocytes
and macrophages, cytotoxic and natural killer cells, and antibodies to the antigen. The procedure
for testing the progression of the disease is based on assumptions of initial concentration of HIV
virus present in blood at the moment of transmission. We have considered three cases of AIDS
progression in which the initial concentration of the virus is varied from 10 to 100 virus particles/μ|
of peripheral blood. These cases are simulated again using the detoxification unit.
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CHAPTER 2

PHYSIOLOGY OF THE IMMUNE SYSTEM
The body, a multicellular organism, may be thought of as an ecosystem containing
numerous niches that can be occupied by organisms uniquely adapted to the prevailing
environment. One such niche in this ecosystem is the cell, which can be invaded by foreign
disease-producing organisms.
The immune system is made up of a complicated network of white cells and chemical
products which interact synergistically to eliminate foreign invaders, abnormal cells, and toxic cell
products (Figure 2.1).
Basically there are have two special types of white cells; monocytes and macrophages,
and the lymphocytes.
The white cells originate from the stem cells found in the fetal liver and the bone marrow.
They differentiate Into many cell types as they mature and these cell types may have separate or
overlapping functions. Most white cells in the blood are short-lived scavenger cells (neutrophils)
that engulf and digest foreign microbes and die.
The reticulo-endothelial system comprises monocytes and macrophages. The monocytes
and the macrophages are also scavenger cells, but they have a longer lifetime, perhaps months or
years. They are particularly good at detecting, engulfing, and digesting tumors or virally Infected
cells. Some monocytes circulate in the bloodstream and later in life receive immune signals from
the lymphocytes that cause the monocytes to migrate into tissues and transform into tissue
specific macrophages. From that point they follow two pathways; either they wander freely
through the connective tissue in organs or attach to the basement membrane of the tiny capillaries
in those organs. Most of the monocytes differentiate directly into tissue specific macrophages. The
macrophages are concentrated and strategically located in organs like the liver and lungs, and in
the lymph nodes. These tissues receive blood from the parts of the body that are exposed to the
outside world. If the invading organism escapes this early level of immune defense, then they
reach a second level of defense which is provided by the spleen, kidney, joints, and brain. This
system is one major line of defense.
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Another major line of defense in the immune system is the lymphoid system, a set of
glands, organs, and cells. The T and B cells are manufactured and shipped from the lymph nodes
that are situated throughout the body. In the process of maturing the lymphocytes differentiate
into hundreds of thousands of lymphocyte subgroups, each very small and each designed to
recognize and mount a defense against a specific foreign protein or antigen.

Basic Functions of the immune system
Immunology is concerned with cells and molecules spread throughout the body, the functional
connections between which have been apparent for at least 40 years.
The task confronting the natural defense system can be capsulized in six key words:
Encounter, recognition, activation, deployment, discrimination and regulation.
Before the immune response is invoked, the invading microbe and antigens derived from
it must encounter cells capable of responding.
There are several kinds of antigens and their entry into the body depends on the category
or class of antigen to which they belong.
Precise and elaborate mechanisms target antigens to sites where the opportunity for
encounter with lymphocytes is optimized. Obviously since immunity is specific, molecular
mechanisms of recognition must exist. Both the antigen-specific receptors on lymphocytes and
the antibody molecules that are eventually formed must recognize and unite with particular
antigenic molecules or molecular fragments. It is impossible for the immune system to know in
advance which specific type of antigen it may be asked to recognize. With the invasion of the
antigen the system must somehow posses the capability of responding to it.
After recognition the lymphocytes must be activated to respond, either by producing
antibodies or by acting in the inflammatory response. The antibodies or the lymphocytes alone
cannot rid the body of the invader. Instead, they cooperate in an elaborate deployment strategy,
amplifying and distributing the defense function and collaborating their attack with other
non-antigen -specific cells (such as macrophages, phagocytes) or molecules (such as the
complement system) in destroying and eliminating the pathogen.
The immune system has the ability to discriminate between self and non-self, thereby
avoiding auto-immune tissue damage.

The immune system tolerates many autologous antigens. The positive and negative
feedback loops control the different components of the immune system and maintain them within
the permissible range, thus taking care of immune regulation.
Macrophages entering the lymph nodes or interacting with lymphocytes in tissues have
the job of presenting foreign antigen to the appropriate lymphocyte subgroup and thereafter
activate it. The process involves engulfing and digesting foreign cells and infected cells,
incorporating into their surface the proteins of the foreign invaders. The foreign antigens are
inserted on the macrophage surface next to other normal receptors, called MHC antigens
(antigens of the major histocompatibility complex). The MHC antigens are part of the associative
recognition network of surface receptors that enable the macrophages and lymphocytes to
recognize each other as parts of self and to receive appropriate instructions from each other.
When a foreign antigen is present on the macrophage surface, only those lymphocytes that
recognize or bind to both an MHC receptor and the specific foreign antigen are activated.

IMMUNOLOGY OF AIDS
Helper/inducer T lymphocytes bearing CD4 protein molecules have been termed as "the
leader of the immunological orchestra" because of their central role in the immune response
[4,5,6,7,8] (Figure 2.2).
Many immune responses are induced by dual recognition between a T4 helper cell and an
antigen presented by macrophage. Contact between T4 cell receptor, the MHC (major
histocompatibility complex), and the foreign antigens of the macrophage stimulates the T4
lymphocytes to send out chemical instructions to other immune cells. The chemical instructions in
the form of lymphokines, induce a variety of effects: they activate monocytes and macrophages,
thereby enhancing their ability to engulf and destroy the invading pathogen; they stimulate
cytotoxic lymphocytes, called T8 killer cells, to proliferate and kill infected cells. They also
stimulate B lymphocytes to proliferate and produce antigen specific antibodies capable of binding
to the foreign antigen [1].
The main target of the virus is the helper/inducer cells which is a subset of Thymus
derived (T) lymphocytes. HIV infects T4 cells by binding to the CD4 protein receptor present in
great abundance on the surface of these cells [4,5,6,7,8,9,10]. Some monocytes and
macrophages, and some B cells also carry CD4 molecules on their surface [5,6]. When HIV
attacks a T4 helper cell, its envelope glycoprotein (gp120) binds to CD4 [4,5,6,7]. The stem
(transmembrane protein gp41) attached to gp120 then inserts itself into the cell membrane; the
viral and cell membranes fuse together; and the virus dumps its genetic contents into the interior
of the cell [5,6,7] (Figure 2.3). Thus, by taking advantage of the recognition network in the immune
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system, the virus gains entry into cells that are attempting to fight off foreign invaders. The
destruction of CD4 bearing lymphocytes probably accounts for the immunosuppressive effect of
the virus.
The normal function of the T cells is thus impaired and the ability of T cells to recognize
foreign substances and stimulate B lymphocytes is lost. As a result B cells are unable to multiply
and produce specific antibodies that destroy the invading virus [7]. In addition, infected helper T
cells serve as hosts where the virus flourishes until the host cells rupture and introduce large
amounts of virus into the blood stream [6] (Figure 2.4).
The progressive decline in the number of T4 cells is correlated with the progression of
AIDS from the initial infection stage to the terminal stage [4 - 8,11].
Individuals may remain seropositive and healthy for long periods but a hallmark of disease
progression is an inexorable fall in the number of helper/inducer CD4 positive cells [7,11]. In full
blown AIDS there is also a fall in the number of CD8 lymphocytes [4,7]. The
monocyte/macrophage function, including the ability to kill intracellular parasites, is impaired [Al.
Natural killer cell activity is also decreased [9,10].
The simplest hypothesis for the cause of immune deficit is the destruction of
helper/inducer T cells and probably also monocytes and macrophages by the virus [5,6]. Another
possibility is that the envelope glycoprotein of the virus which binds to CD4, may interfere with the
normal function of this molecule. Since CD4 plays a part in the interaction of helper/inducer T cells
with other cell types it would block their normal function and result in immune dysfunction [4].

WHITE CELLS OF THE IMMUNE SYSTEM

FUNCTION OF T -HELPER CELLS CELLS

HIV ATTACKS

T -HELPER CELLS

INFEC ION
T

OF

CELLS

CHAPTER 3

MODEL OF THE IMMUNE SYSTEM
The mathematical model presented here is developed using the concept of single
compartmental analysis [12 - 14]. The central aspect incorporated in the model is the
multiplication and destruction of white blood cell populations. Destruction, either by cell
malfunction after combining with the antigen or normal cell aging, is possible.
The virus multiplies at a certain rate in the patient [5 - 7,12,13]. This rate is proportional to
the number of infected T cells because these cells provide a niche for the virus. Within the infected
T cells the virus can stay transient for a certain period but when the virus gets activated it
multiplies at a very high rate. The cells burst and the virus spreads in the blood stream [5,6]. T
cells, the primary proponents of the defense system, are unable to produce stimulating chemicals
for the immune components to respond against the virus, hence the entire immune system
completely breaks down.
If appropriate measures are taken in the initial stage, there can be an elimination or at
least reduction in the number of infected cells, thus resulting in a decrease of the virus
concentration.
One proposed cure which is presently in the research stage is processing the blood in an
extracorporeal detoxification system (detox unit). In the detox unit the virus and infected WBCs
are removed by selective sedimentation and by the anti-viral device. It is assumed that viral
infection changes sedimentation characteristics of the infected WBCs (a fact demonstrated in
mouse cells by Welsh ) [9-12]. The detox unit is based on the principle that the infected white
blood cells have different sedimentation properties compared to the normal white blood cells,
therefore it is possible to separate them.
There are chances of the cells breaking due to physical agitation and fluid shear stress.
That would rupture the infected WBCs pouring the virus content into the blood stream and also
damaging a few healthy cells.
We have assumed that viral reproduction takes place by infection as well as being a direct
function of free virus concentration [12,13]. Virus multiplies within the cell [5,6,7]. The virus can
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stay quiescent for an unpredictable duration. We have assumed that there is constant
multiplication of virus [12,13).
From the above discussion the following relations can be written down:

Antigen yields antigen

Infected cells yield antigen

We have assumed the destruction of the antigen and monocytes or macrophages after binding
together. These should be extended to include the cases where antigen is destroyed without
killing the monocytes or the macrophages.

We have assumed the destruction of the cytotoxic cells and antigen after binding together. This
term should also be extended to include cases where antigen is destroyed without killing the
cytotoxic or natural killer cells.

Death refers to destruction of monocytes or macrophages and the infected cells.

Antigen and T4 cells bind together to form a complex.
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Production of cytotoxic cells by the stimulus of the [TAg] complex

Cytotoxic cells attack the infected T cells, resulting in the destruction of both the cells.

Formation of infected T cells from the [TAg complex.

Destruction of the complex in the body due to high concentration of antigen.

Destruction of cytotoxic and NK cells by infected T cells.

Antibody production is stimulated by T-Ag complex

Antibodies are destroyed by infected T cells
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Antibody binds with antigen resulting in destruction of both the molecules.

Infected cells break due to detox unit and release antigen

System Equations
Combining the above equations, the overall system of differential equations can be
described as :

Change in Antigen concentration with respect to time:
The antigen concentration is directly proportional to free antigen concentration [Ag] and the
number of infected T cells [Ti]. The antigen concentration decreases when immune cells
(monocytes [M], T4 cells [T], cytotoxic cells [Tc] and antibodies [Ab]) combine with the antigen.
When the detox machine is turned on some antigen may be released in the blood stream due to
the breakage of the infected cells (Nd [Ag])and some would be removed by the detox unit.

Change in T4 helper cell concentration with respect to time:
The T4 cell concentration is proportional to the production of T4 cells (k6/(k13+ [T])). The
concentration decreases when T4 cells combine with the antigen [T] [Ag] to form antigen-T cell
complex [TAg]. Their concentration also decreases when the T4 cells combine with the infected
cells ([T] [Ti]), thus forming syncytia. The concentration of 14 cells is proportional to the
destruction of T4 cells (k14*T/(k16+T)) due to aging.

Change in other CD4 cells (monocytes and macrophages) concentration with respect to time
:
The concentration of CD4 cells other than T4 cells increases with their production rate
(k8/(105 + M)) and decreases with theirdestruction rate (10 7*Mi(k18 + M)). The concentration of
these cells may also decrease when these cells combine with antigen ([Ag][M]) or infected T cells
([M] [Ti]).

Change in Cytotoxic and natural killer cells concentration with respect to time:
The concentration of cytotoxic and natural killer cells is directly proportional to the antigen-T cell
complex [TAg]. This complex stimulates the production of cytotoxic cells which develop from
mature T cells. Their concentration decreases when the cells attack the antigen ([Tc][Ag]) and the
infected cells aTc][T1]). The concentration also decreases as the number of infected cells [Ti]
increases.

Change in Infected cell concentration with respect to time:
The concentration of infected cells increases when the T cell-antigen complex [TAW results in
infected T cells. The infected T cells also combine with healthy T cells ([T][Tip, thus forming
syncytia which further increases their concentration. The infected T cells concentration decreases
when the cytotoxic cells, NK cells ([Tc][Ti]), monocytes or macrophages ([M][Ti]) recognize the
infected cell and try to destroy it. When the detox unit is turned on some infected T cells may be
removed and some may break.
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Change in T cell and antigen complex with respect to time,
The complex concentration increases proportionately to the concentration of antigen as well as T4
cells ([T][Ag]). Their concentration decreases if the complex [TAg] transforms into an infected T
cell [Ti] or the complex is destroyed due to high concentrations of the antigen [AM.

Change in Antibody concentration with respect to time:
The antibody production gets stimulated by the T cell-antigen complex [TAG] and the
concentration decreases proportionately to the number of infected T cells [Ti]. Their concentration
also decreases with the combining of antibody to the antigen [Ab] [Ag].

where :
Ag
T
M
Tc
Ti
TAg
Ab
k1
k2
k3
k4
k5
k6
k7
k8
kg
k 10
k 11
k 12
k 13
k 14
k 15
k 16

antigen concentration per μl
T4 helper cell concentration per μl
other CD4 cells (monocytes and macrophages)
cytotoxic and natural killer cells concentration per μl
infected T4 cell concentration per μl
concentration of T4 cell and antigen complex per μl
antibody concentration per μl
rate constant for antigen multiplication
rate constant for antigen replication within an infected T4 cell
rate constant for destruction of other CD4 cells and antigen after binding.
rate constant for destruction of cytotoxic and NK cells , and antigen after binding
rate constant for destruction of other CD4 cells and infected T4 cells after binding
rate constant for normal production of T4 cells
rate constant for formation of T4 cells and antigen complex
rate constant for normal production of other CD4 cells
rate constant for production of cytotoxic cells stimulated by TAg complex
rate constant for destruction of infected cells and cytotoxic cells after binding
rate constant for formation of infected T cells
rate constant for destruction of TAg complex
rate constant for regulation of T4 cell production
rate constant for normal destruction of T4 cells
rate constant for regulation of other CD4 cells production
rate constant for regulation of T4 cell destruction
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rate constant for normal destruction of other CD4 cells
k 17
rate constant for regulation of other CD4 cells destruction
k 18
rate
constant for destruction of cytotoxic and NK cells due to infected T4 cells
k 19
rate constant for formation of syncytia
k 20
rate constant for production of antibodies
k 21
rate constant for destruction of antibodies due to infected cells
k 22
rate constant for destruction of antigen and antibody after combining
k 23
rate constant for the breakage as well as removal of infected cells and release of Ag
k 24
rate constant for the removal of antigen by the detox unit
k 25
average
number of virus from breakage of infected cells by detox unit
Nd

CHAPTER 4

ESTIMATION OF MODEL PARAMETERS
Clinical data were available for the concentration of T4 helper cells, monocytes and
polymorphs in healthy individuals. The normal count of T4 cells is 10001µl and the combined
normal count of monocytes and polymorphs is 50004/1[15]. The concentration of cytotoxic cells
and antibodies to the virus are zero for an individual not infected by AIDS. Assuming the
concentration of antigen to be zero, the production and destruction rate constants for differential
WBCs are calculated.
Using engineering and physiological judgment, the equations have been formulated so
that the rate of production is equal to the rate of destruction of the cells at homeostasis. The cell
reproduction rate is not a direct function of cell type, however, a high count of differential cells is
an indication of specific type cell reproduction ability [12,13]. The production and destruction rate
of the differential WBCs may vary from patient to patient depending on their health. For this model
we have assumed a value and kept it constant in all the case studies.
STEP 1:
This is a simple case where no AIDS virus is injected in the body. It is the starting case for
the simulation model. It has been shown that with no introduction of the antigen, the differential
components of the white cells remain unchanged. When no HIV antigen is present in the human
body, a healthy state is maintained by the individual. This condition is applicable to a healthy
person whose differential WBC count is always maintained normally. The results obtained from the
simulation of this step is shown in Figure 1. This model is rigid with absolute numbers but in
reality, concentration of cells in the body may vary slightly above or below the rigid line.
STEP 2:
The next step in deriving the parameters is to simulate a case of perturbation and
recovery to homeostasis. In this case the initial parameter of any component of the immune
system is shifted from the normal concentration. After a certain period of time, the cells whose
concentration was shifted come back to their normal required concentration within the body. In
the model this period can be varied by increasing or decreasing the rate constants responsible for
production or destruction of the respective cells. For example, we can shift the initial
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concentration of T cells to 500 Jul which is much less than the normal value (Figure 2). At first the
rate of change of T cells is high in order to get the T cell concentration closer to the normal range.
The rate of change of T cells is dependent on the rate constants K 6, K13 , K14 , K16 .
Increasing K6 increases the concentration level due to increase in the production rate.
Decreasing K14 also increases the concentration of T cells since it corresponds to the destruction
rate of T cells. When the concentration is decreased below 1000 /ul, K 13 works effectively in
bringing the concentration back to normal by creating an additive effect in the denominator value.
The denominator value is decreased due to which reproduction rate increases. K 13 is primarily
needed to prevent an abnormal positive spike of T cells. It is necessary that the rise in T cells be
gradual.
Rate constants K 14 and K16 work similarly. For a healthy person T4 cell concentration is
equal to the value of the rate constant K16 . When the T cell concentration decreases the
denominator value decreases proportionately and the numerator value also decreases
considerably because K14 is a direct multiple of T4 cell concentration. The overall result is
decrease in the destruction rate. K13 and K16 are the rate constants for the regulation of T cells in
order to maintain their level in the normal range. Thus when there is a decrease in the T4 cell
concentration, reproduction rate is increased and the destruction rate is decreased, the overall
effect being an increase in the concentration of T4 helper cells back to normal.
Thus, if the normal cell count of T4 cells or polymorphs were decreased due to some
infection other than HIV, the immune cells reach normal levels after a certain period of time as
shown in Figure 2. This case also proves that other infections do not destroy the immune structure
completely and that the individual can recover. The duration of recuperation depends on the
production and destruction rate constants. Table 1 shows the initial values of the variables
parameters used in the model.
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Table 1
Initial Concentrations:

Case 1
Antigen

=

Initial Conditions
T4 cells

Case 2
50.0// μl
10.0/
Antigen
=
μl

Case 3
Antigen

100.0μl

Rate Constants

other CD4 cells
cytotoxic, NK
infected T cells
T Aq complex

=
=

=

=

0.0

=

0.000000001

=

4.0

Antibodies

=

0.0

=

1000.0

=
=

0.0009

=
=

5000.0
0.022

10100.0

=

0.00001

=

0.00004

=

0.0001

=

0.0000001

=

0.09

=

0.000001
0.00041

=

0.00001

=

k13
k14
k15
k16
k17
k18
k19
k20
k21
k22
k23

50.0
1.8
50.0
1000.0

0.0000001
1.2
0.000001
0.0001

-

k3
k8
k1
k2
k4
k5
k6
k7
k9
k10
k11
k12 =
=
=

=
=
=
=

1000
5000
0.0
0.0

=

By studying the reaction of antigen binding to the different immune cells, we assumed that
each combination is proportional to the concentration of the two cells involved. The rate at which
the antigen combines with the differential WBC cells is assumed with the knowledge of their
functional behavior in response to the virus.
This is a patient customized model. Periodically WBC counts of the patient should be
taken. The change in the condition of the patient's health should be perused for a few days to
provide patient specific values for the constants in the model. Deterioration of the patient's health
should also be used when calculating and verifying rate constants in the above equations.
The patient specific model should then be simulated, thus detecting tolerance to the virus.
Response to the infection can be studied by plotting a graph of differential WBC components
versus time. Once the immune system is tracked, different approaches can be simulated for the
patient's treatment. Diverse drugs can be tested using the model and the results obtained from
simulation can help the doctor in selecting the best treatment for that patient.

HOMEOSTASIS CONDITION

RECOVERY TO HOMEOSTASIS

CHAPTER 5

Experimental work performed using extracorporeal detoxification unit
The primary objective of the experimental work was to attain optimization of white blood
cell separation.
This chapter deals with the experimental techniques and features of the detoxification unit
[13,18,20-23]. A centrifuge (detox unit) with anti-twister mechanism is used in the blood cell
separation technique which causes very little damage to the cells. There are many features that
render this fractionation technique unique. In this technique, no density gradient chemicals or
chemical sedimentation agents are used. The experiments have been performed in a seal-less
centrifuge using a trapezoidal chamber head.
The experiments were performed in order to find the optimal regime for a good blood cell
separation in the first stage. This was done because we expect a large variation in blood
characteristics such as hematocrit (HOT), red blood cell (RBC) concentration, white blood cell
(WBC) concentration, hemoglobin etc. from one patient to another, which will cause various
separations to take place.
The critical parameters for a good separation are HCT, centrifuge speed, withdrawal rate
and residence time of blood in the chamber. A method has to be developed that can account for
separation efficiently on a patient to patient basis. This device can be directly hooked to the
patient and blood processing can be done on-line.
Our technique of separation has proven to be very efficient and the separation that
previously was obtained via a six stage process [22,23] can now be achieved in a single stage.
The separation of the first stage provides us with WBC enriched plasma which can be
further used for multistage separation. The chamber used in the first stage is also utilized in the
second stage separation. Multistage separation is expected to give a separation of differential
WBCs which in turn could be studied for healthy and unhealthy white cells.
In the first stage, the initial conditions were varied for the assay and the results were
compared. The main parameter which was altered for different observations was the hematocrit
(HCT) of the blood. In latter experiments second stage separation was also performed, that is,
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blood samples enriched with the white blood cells were collected from separation of the first
stage, and spun again in the centrifuge to gain further purity of the white cell collection.
The results of first stage separation and second stage separation presented different
graphical outputs.
Sedimentation Theory in application to blood processing separation technique.
This section follows the mathematical development of Van Wie [18] and Sofer and Van
Wie [21-25]. The Stokes' equation is the fundamental principle of sedimentation theory [18]. It
describes sedimentation in dilute suspensions. It is very useful in predicting the particle velocity or
sedimentation rates. Under a centrifugal force field, the value of the sedimentation rate is given by:
2

μ

(ρi-f)ω 2 /

c

Si=2/9r

r

ω2

where:
Si
r

= terminal sedimentation velocity of species i;
= the radius of species i ;
= angular acceleration exerted due to the centrifugal
force;
= density of species ;
ρi
= plasma density ; and
ρf
μ = viscosity of the suspending fluid medium .

Modifications are made in this basic formula to include blood characteristics. The
Hawksley-Vand modification of the Stokes' equation is used to explain individual blood cellular
species.
When whole blood is allowed to stand in a test tube, gravity causes settling of various
blood fractions into respective layers. The red blood cells have a higher density compared to other
suspended particles in blood, and they also tend to adhere to each other forming rouleaux, which
augment their settling to the bottom of the test tube.
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The white blood cells, which are less dense form a buffy coat over the red cells. Plasma
with some salt minerals, carbohydrates, lipids and proteins appears on the top.
The rate of sedimentation is speeded by imposing angular acceleration in the centrifugal
process. The centrifugal speed is limited in order to prevent shear damage to the cells under the
influence of very high rotating velocity.

THEORY
First step is to study the sedimentation process of centrifuged, whole blood particles in
general. Next, we will study the different cases by varying the HOT and holding the centrifuge
speed and the withdrawal rates constant.
According to the fundamental principle of circular motion, centrifugal force increases as
the radius increases. This is the reason the higher density particles get pushed towards the outer
diameter of the chamber.
Applying this principle to separation of blood components, it is obvious that RBCs get
pushed towards the outer diameter and displaced plasma along with some minerals move closer
to the axis of the machine. After a certain duration of time, a distinct separation line is observed in
the chamber between the packed red cells and yellow colored plasma. The WBCs form a buffy
thin coat between the RBCs and the plasma medium.
The separation front is the interface between the plasma phase and cell phase. Static
mode defines the duration of the batch process. The distance of this front from the inner side of
the chamber increases in the static mode. As time progresses in the static mode, the separation
front gradually moves towards the outer diameter of the chamber, until it reaches a specific
position, after which it does not move. This phenomenon can be explained in the following manner.
Initially, RBCs move individually towards the outer side of the chamber and they collide
with each other and clash against the chamber wall. The sedimentation velocity increases as
rouleaux formation takes place along with the settling mechanism. When the RBCs have almost
settled in their respective positions, they get packed together and cannot move any further. From
that time onwards the separation front does not seem to move any further beyond that particular
line of packed cells.
Centrifuge Equipment

The centrifuge used for the purpose of blood cell separation was first developed by Ito
and Kolbow at NIH. A new machine was constructed by Sofer's group at the University of
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Oklahoma and brought to NJIT in 1986. The trapezoidal chamber head was designed Sofer and
Camp of this laboratory. This design is based on Boycott's principle of tapering (slanting) edges.
The centrifuge speed can be varied between 500 to 2000 rpm. For our experiments, we maintain
the speed constant at 900 - 1000 rpm. The essential attributes of the blood fractionator are a
dynamic bearing balance system to reduce vibrations, Tygon tubing for the entry and exit of blood
to and from the chamber, a peristaltic pump for control of the blood process stream, and an
anti-twister mechanism to connect the tube directly to the rotating centrifuge rotor in order to
prevent any twisting or shearing of the tube and damage to the cells.
Experimental Procedure
Bovine blood has been used for the experimental analysis because of two reasons - cow
blood is less hazardous to work with than human blood, and it is easily available.
Blood was stored at a low, constant temperature in the refrigerator. Before feeding it in the
chamber it was stirred properly. Initially the blood was strained through cheese cloth which was
slightly soaked in anti coagulant diluent (ACD) solution to remove external impurities. The blood
chamber in the centrifuge and the connecting tubes were rinsed with ACD solution two to three
times before the run. A constant volume of blood (21 ml) was fed through the tube which enters
the chamber at its midpoint. The initial parameters, which remained constant throughout the run
were defined for the experiment. Centrifuge operating speed was maintained close to 1000 rpm for
the runs. The speed of the machine has a bearing on the time required for the separation.
Increasing the speed exerts more centrifugal force which reduces the time to achieve separation.
The flow of blood into and out of the chamber can be regulated; in our runs it has been
maintained constant at 10.4 ml/min at a motor setting of 150 rpm.
Blood was spun in the chamber till the separation front (distinct red cell layer and yellow
plasma layer) became prominent to the eye and was from 0.5 cms to 2.5 cms in width. This width
depended on the static spin duration of blood in the chamber.
Following this static mode with no input to the chamber or output from the chamber, was
a dynamic mode. In the dynamic mode the chamber inventory was withdrawn. Blood from the
bottom of the chamber was extracted and collected in equal amounts (approximately 3 ml) in 7
test tubes. Because the blood withdrawal port was on the outer side of the chamber the first few
samples of blood had a high concentration of RBCs. As the withdrawal progressed less viscous
and lower HCT blood was collected and at the very end plasma was left in the last test tube.
Volume and time required for each sample were noted. The samples were kept on ice.
Each sample was stirred using a motorized propeller. The HCT of the samples was determined
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using the microhematocrit technique. RBC, WBC and platelet counts in each sample were
determined with a Coulter Counter model ZBI.
Results obtained from the experiments were graphed. Fraction of individual cell type
withdrawn was plotted against the fraction of total blood volume withdrawn.

EXPERIMENTAL RESULTS
Good separation is very critical and it depends on a number of factors such as HCT,
batch duration, distance of the separation front from the inner diameter of the chamber, centrifuge
speed and the pump withdrawal rate.
In our study of assays, the speed and the withdrawal rate have been kept constant. The
duration of the run is a variable factor dependent on the separation front. This in turn is dependent
on the HOT of blood. If the HCT of the blood is low, then the separation front is visible much faster
and the plasma phase is greater volume than the cell phase. On the other hand, if the HCT is very
high, the spin duration is longer and the plasma phase is smaller compared to the cell phase.
The following table shows the initial parameters of each run and the results of their
separation.
HCT of blood

SPEED

(rpm) of TIME

the centrifuge

(sec) P A R T I T I 0 N COMMENTS

duration of the (%)volume

Blood returned to

static portion of

the patient can

the run

have RBC%
WBC% of the total

49
44
42.75
40.4
40.7
37
31.8
30.3
27.9
19.9
9.9
8.3
5.4
4.2
2.0
2.11

900
900
900
900
1100
910
900
950
900
900
900
900
900
900
900
1000

4500
5600
4560
4500
1980
4740
4500
3300
3000
3300
1800
1800
1800
2100
1800
3060

65
78
85
80
40
50
40
35
25
25
18
15
10
10
10
60

blood volume.
85
35
40
92
98
18
28
96
78
8
88
36
30
88
76
35
56
20
38
90
84
28
84
30
80
58
84
76
78
88
96
62
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The effect of HCT on cell separation is visualized by plotting percentage fraction of red
blood cells and white blood cells v/s the volume of blood recovered from the chamber.
After performing a number of experiments at different HCTs, it was found that the optimal
operating condition for the centrifuge occurred at HCTs in the range of 40%-45%. The machine
operating speed was 900 - 1000 rpm, withdrawal flow rate was 10.4 ml/min at a motor setting of
150 rpm.
The maximum difference between the ordinates of RBC and WBC concentrations on the
graph defines the partition for the blood samples. To the left of this partition, blood samples are
rich in RBCs and to the right of this partition the blood samples are rich in WBCs.
Comparing two graphs in the optimum regime, we can see from Figure 5.1 that the
partition at the sixth cut is excellent. To the left of the sixth cut, there is RBC enriched blood which
can be given back to the patient. That is, 85% of the blood volume used for the experiment can be
returned to the patient. The remaining blood is highly concentrated with WBC which can be
diluted with plasma and recycled for further separation. The static mode spin duration for this run
was 4500 sec.
In Figure 5.2, the experiment has the same initial conditions as the previous run except for
the batch duration. The static mode was much shorter. The graph shows an excellent partition at
the third cut, which implies that only 40% of the blood volume can be given back to the patient.
The blood returned to the patient has 80% of the total RBCs and 20% of the WBCs.
From the two graphs we can conclude that the residence time of blood in the chamber is
an important factor for determining the percentage of blood to be returned to the patient. In other
words, the partition for the blood volume (difference in the ordinates) is dependent on the batch
duration.
Comparing the plots of different HCTs (shown in Figures 5.3 - 5.13), some prominent
observations are:
1. As HCT is decreased from 45% to 4%, the area within the curve becomes smaller.
2. As HCT is decreased, the required static residence time of blood in the chamber also
decreases.
3. For high HCTs, the WBC slope rises very gradually in the beginning and then suddenly
shoots up; whereas, as HOT is lowered, the slope becomes steeper and WBC curve runs nearly
parallel to the RBC curve.
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A closer evaluation of these graphs shows a partition for the separation of the RBC and
WBC blood samples. In most of these graphs the partition is seen in the second or the third cut.
When the HOT is lowered to 4.0%, there is an inversion of the WBC and RBC curves. A
point of intersection between the two curves is seen at this HCT ( Figure 5.14).
At very low HCTs the RBC concentration is low in the suspended plasma medium. There
is no rouleaux formation and since WBC are bigger in size than RBC, they tend to settle faster.
In Figures 5.15 and 5.16, HOT at 2%, it is seen that the WBC curve is above the RBC
curve. It is clearly seen in both graphs that an inversion takes place - WBC, not RBC, are the heavy
components. In the first graph, the spin duration was only 1800 sec, whereas in the second graph
the spin duration was increased to 3600 sec which resulted in a better separation. Once again it is

proved that time plays a critical role in the overall separation of the blood components.
The other difference between the two graphs, which is very important to note, is the
formation of the blood sample in achieving the desired HCT prior to the run. For Fig. 5.15, bovine
blood was directly diluted with plasma to get HCT of 4%. For Fig. 5.16, the blood samples rich in
WBC were collected from the first stage and then diluted to get the desired HCT. The WBC/RBC
ratio was higher in the second graph (Fig. 5.16).
This means recycling of the desired blood fraction from the first stage gave a better
separation. This was first proposed earlier [24-25] and is herein confirmed.
The second stage gives more purity of WBC concentration and it is one step towards
multi-stage centrifuging technique for separation of differential white blood cells.

In conclusion we can say that a search for the optimum condition of the centrifuge is very
important in order to achieve efficiency in separation.
For the first stage, the favorable operating regime was found to be in the HCT ranging
from 40% - 45%. Centrifuge speed for separation should be limited to prevent shear damage to the
cells. The change in withdrawal rate does not have a very great bearing in the overall separation.
Nevertheless, it must be kept constant and within the range to allow continuous flow of blood to
and from the chamber. If the flow rate is increased too high then the blood due to its high
viscosity, gets plugged in the tubing while flowing out of the chamber.
Residence time of blood in the chamber is the key operating factor for the partition
between the blood samples. The occurrence of this partition in the graph determines the amount
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of blood that is rich in RBC and can be given back to the patient, and the amount of blood rich In
WBC which can be further processed. The WBC enriched blood collected from the first stage
provides the input for the second stage. The second stage gives further purity of WBC
concentration. The multistage separation would result in the separation of differential components
of the white blood cells.
This study provides a basis for the separation technique and further research in this field is
expected to give better results in the blood cell separation.
Recently experiments with human blood (donated by Sam Safer) were performed at
UMDNJ. The separation of white blood cells in human blood was achieved faster as we had
predicted, compared to cow's blood. Also the separation on the whole was better.
We intend to exploit this technique further to process human blood and achieve
separation of differential white blood cells. With the basic knowledge of fractionation,
modifications can be implemented and success can be achieved in the separation of infected
white cells from the healthy white cells which is proposed by us for the cure or at least longer
survival of an AIDS patient.
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CHAPTER 6

SIMULATION RESULTS AND DISCUSSION
Modeling and simulation arebeing used in various ways to explore the intricacies of the
mmune system. Our starting point is that one needs to have a good understanding of the
elementary building blocks before beginning work with larger simulation models.
The present state of biological knowledge does not yet give us a reliable means of
predicting the manifestation of AIDS after HIV transmission. However, a simulation approach
based on a mathematical model can be quite useful. This thesis describes a basic model of AIDS
dynamics in the form of differential equations with the application of a FORTRAN program. The
model consists of several parameters which describe the immune changes accompanying the
progression of AIDS.
The solution of the differential equations was achieved by applying the Gear algorithm
[16,17]. The simulation was done on a personal computer (PC-80286). The results presented in
this paper are discussed within the framework of the Walter Reed classification system [7]. The
figures are plotted from the simulation calculations, where HIV is the only cause of death. Table 2
shows the different stages in Walter Reed classification based on T4 cell counts.
TABLE 2

WALTER REED CLASSIFICATION
STAGES
Stage 0
Stage 1
Stage 2
Stage 3
Stage 4
Stage 5
_Stage 6

T4 CELL COUNT
800-1000
>400
>400 (chronic adenopathy)
<400
<400
<200 (energy
< 00 full blown AIDS

The Walter Reed classification begins with Stage 0. This stage is exposure to HIV. In the
model exposure corresponds to a known initial concentration of the virus, 10 virus cells/ μ l. The
main reason for initializing is that we have to force the mathematical model to respond to the
presence of the virus.
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Figure 6.1 and 6.2 show the rise in the concentration of the virus with respect to time. As
seen in Figure 6.1 (microscopic view), the concentration of virus in the beginning is high due to
the initial transmission. When the body is challenged with the virus, the immune system activates
and resists the foreign particles. The concentration of the virus decreases. The individual is said to
suffer from viremia. The disappearance of the virus indicates that initially the immune system
functions effectively.
From six weeks to a year after the transmission of the virus, antigen concentration
increases for a short while and then decreases, going back to zero. This small "blip" represents
the acute infection in the victim which is the Stage 1 in the progression of AIDS. Following this
"blip" is the latent phase of the antigen. This is Stage 2, in which the patient suffers from chronic
lymphadenopathy. The antigen is hidden in the T4 helper cells and cannot be detected by
conventional methods like ELISA or Western Blot. It lies dormant indefinitely in T cells, inextricable
from the cell and hidden from the victim's immune system. The antigen stays quiescent for a long
period and then starts to multiply within the cells when activated. The beginning of Stage 3 is
defined by a persistent drop in the T4 cell count to less than 400/μ|. Stage 4 follows a few months
later. The T4 cell count drops persistently lower. It can go below 50 cell/μ|.
Progression to Stage 5 is usually determined on the basis of development of energy. The
fifth stage is known as AIDS related complex (ARC). In this phase the Immune system becomes
weak and the body becomes susceptible to other infections. In this opportunistic infection phase
the antigen concentration in the blood increases exponentially. The T4 cell count falls less to
200/μ|.
Most people enter Stage 6 when the T4 cell count reduces to 100/μ| or less. This last
stage is full blown AIDS. The replication of the virus flares up and the infection enters the final
stage. The concentration of the antigen is very high and it slowly saturates towards the end. In the
model, simulation results show that towards the end antigen has significantly decreased rates of
multiplication. This aspect will be further explored in later versions. This last stage of the disease
results in death.
In Figure 6.3, T4 helper cell concentration is plotted against time. In Stage 1, T4 cell
concentration is almost normal. It stays constant around 800-1000 cells/μl. Within six months to a
year chronic lymphadenopathy develops. The T4-cell count slowly declines. In Stage 2 the decline
is faster. The cell count goes to 400/μ|. The declining rate is higher in Stage 3. The count falls
below 400/μ|. In Stage 4 the cell count goes persistently lower. The cell count further reduces to
200/μ|. The cell count decreases to 100 in the fifth stage. Finally in Stage 6, full blown AIDS, there
is hardly any trace of T4 cells. The antigen replicates wildly, killing the remaining T4 cells and
hence any vestiges of the immune defense.
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In Figure 6.4, monocytes and macrophages are plotted against time. Some monocytes
and macrophages also carry CD4 receptors and they are attacked by HIV. They get infected and
their number decreases with progression of AIDS. in the initial stages their number stays constant
for a long time, but towards the terminating stage their number decreases.
Figure 6.5 is plotted for cytotoxic and natural killer cells. Cytotoxic cells have CD8 surface
molecules. In a healthy person there are no cytotoxic cells. In case of infection the number of
cytotoxic cells and natural killer cells increases in order to engulf the toxic antigen and rid the
body of unfavorable substances. In this case initial concentration of cytotoxic cell is zero. When
the person becomes infected the number of cytotoxic cells and natural killer cells increases.
Functionally this is predicted in any infection. This fact is verified by clinical results that show
increase in the CD8/CD4 cell ratio. The model comfortably simulates their production, circulation
in blood in the second and third stage, and their reduction and destruction in the terminal stage.
The infected cell concentration are shown in Figure 6.6. The model simulates the
conversion of healthy T4 cells into infected T-cells which malfunction due to the presence of
antigen within them. The infected cells carry antigen receptor and combine with healthy T cells
thus forming syncytia [6]. The number of infected cells increases with progression of the disease
and the number of healthy cells decreases constantly.
Concentration of antibodies against this antigen is shown in Figure 6.7. Soon after acute
HIV infection production of antibodies is stimulated. Their concentration rises in Stage 2 and 3. It
stays high in Stage 4 and starts decreasing in Stage 5. In the final stage their number falls rapidly
because the immune system depletes completely.
The three cases presented in this study (refer to Table 1) differ from each other in their
initial concentration of the virus. The 3 cases are briefly discussed in Table 3, as shown below.
Table 3.
Stages

Stage 0
Stage 1
Stage 2
Stage 3
Stage 4
Stage 5
Stage6

Period (days) in a particular stage
Case 3 (100 virus
Case 2 (50 virus
Case 1 (10 virus
0 - 560
560 - 640
640 - 700
700 - 730
730 - 760
760 - 810
810 - death

0 - 370
370 - 480
480 - 530
530 - 565
565 - 595
595 - 650
650 - death

0 - 295
295 - 400
400 - 485
485 - 515
515 - 545
545 - 610
610 - death
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In Table 3 , you can see that as the dose of the initial concentration of the injected virus
increases the patient enters the ascending stages of the disease faster. This survival time of the
patient decreases as the dose is increased from 10 virus particles/μl to 100 virus particles/μl. Case
1 is the summation of the Figures 6.1 to 6.7 and it is plotted in Figure 6.8. This case was simulated
again with the detox unit on. In the model this was incorporated by substituting values other than
zero for k24, k25 and Nd. The result of this simulation case is shown in Figure G.Q. Comparing the
cases with the machine off and machine on it can be easily seen that the concentrations of the
antigen and infected cells are reduced considerably. More virus in the blood means more
infectivity [13]. The initial virus concentration is increased for the second and third case. In the
second case the virus concentration is increased to 50/μ|. Case 2 is shown in Figure 6.10. T cell
concentration decreases more quickly and the survival time of the patient is decreased.This case
is again simulated with the detox unit on as shown in Figure 6.11.
In the third case the virus concentration is increased to 100/μ|. Case 3 is shown in Figure
6.12. The patient manifests AIDS earlier than the patients of the first two cases. The third case is
again simulated with the machine on (Figure 6.13) and it is seen again that the detox machine is
powerful in decreasing the concentration of antigen and infected cells in the blood. The effect of
the machine off and machine on for the 3 cases in shown in Table 4.
Table 4.
Stages

Stage 0
Stage 1
Stage 2
Stage 3
Stage 4
Stage 5
Lao *G

Period (days) in a
particular stage
Case
machine off !machine on
0 - 560
0 - 565
560 - 640
565 - 645
640 - 700
645 -705
700 - 730
705 - 735
735 - 765
730 - 760
760 - 810
765 - 825
,810 - death 825 - death

Case 2
machine off machine on
0 - 370
0 - 390
390 - 495
370 - 480
495 - 555
480 - 530
530 - 565
555 - 585
565 - 595
585 - 615
595 - 650
615 - 675
650 - death 675 - death

Case 3
machine off machine o
0 - 300
0 - 295
300 - 420
295 - 400
400 - 485
420 - 495
485 - 515
495 - 530
515 - 545
530 - 565
565 - 630
545 - 610
6 0 - death 630 - death

INITIAL ANTIGEN BEHAVIOR

ANTIGEN MULTIPLICATION

DEPLETION OF T4 CELLS WITH PROGRESSION OF THE DISEASE

SECONDARY IMMUNE CELLS

CYTOLYTIC ACTIVITY

INFECTED T CELLS AND SYNCYTIA

H U MORAL ACTIVITY

CASE 1

CASE 1 ( Machine on)

CASE 2

CASE 2 C c h the on)

CASE 3

CASE 3 (Machine on)

CHAPTER 7

CONCLUSIONS
This model simulates HIV transmission, the subsequent prolonged period of acute
infection during which the immune system suffers progressive decline and the acquisition of AIDS
related terminal disease, and full blown AIDS. Following the infection contact, the individual enters
a first stage during which viral antigen circulates unchecked. This asymptomatic stage varies,
depending on the infective dose contracted by the individual.
After several weeks to several months, the individual develops antibodies to HIV, a
process known as seroconversion [7]. During the period of acute infection, T4 helper cells which
coordinate immune system responses are attacked by HIV and they are enlisted genetically to
produce more virus. Consequently the infected individual's T4 cell count gradually decreases,
rendering the individual susceptible to opportunistic diseases.
The three cases presented successfully simulate the progression of AIDS. The
model-based investigations show that the theoretical results obtained from the simulation are in
close agreement with clinical observations [19]. This model is flexible; addition of more variables
to provide response details is easily accommodated.
The model can be readily extended to incorporate cytokine and chemotactic reactions
with stimulation of different lymphokines. Antibodies to the core protein and the envelope protein
can be simulated separately. B cells as well as plasma cells can be added in later versions of this
model.
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Chapter 8
Recommendation for further wort,.

Using this model we could not find the smallest dose of the initial concentration of
injected antigen which would not result in AIDS manifestation. The search for this case can prove
to be very useful in determining the threshold of HIV transmission and should be continued. Below
this threshold the patient would not develop AIDS.
This simulation can be extended further by administration of anti-viral drugs to the patient.
AZT which is the present drug used for many patients can be simulated. The dosage of the drug
as well as the time of administration can be studied and incorporated in such a model.
Another research treatment for this disease is the injection of killer cells . The dose and
the time of the killer cell injection can be simulated and studied.
In this model syncytia and infected cells were treated together. Further modeling along
this track can be done by separately accounting for the infected T cells and syncytia. The detox
unit can be simulated for the evaluation of syncytium removal vs infected cell removal.
In the experimental section, for the second stage separations we have not yet been able
to find an accurate measure of the WBC/RBC ratio which gives a better separation. Experiments in
recycling of blood are recommended.
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